Tools

LEADER 02330nam 2200517 i 4500

001 on1406027744;

003 OCoLC;

005 20231026113536.0;

006 m o d f ;

007 cr |||||||||||;

008 231026s2023 dcua ob f000 0 eng c;

035 a| (Sirsi) o1406027744;

042 a| pcc;

043 a| n-us---;

049 a| ERE#;

074 a| 0546-D (online);

086 0 a| GA 1.13:GAO-23-105430;

088 a| GAO-23-105430;

110 1 a| United States.b| Government Accountability Office,e| author.=| ^A580995;

245 10 a| Regenerative medicine :b| therapeutic applications, challenges, and policy options : report to congressional committees /c| United States Government Accountability Office.;

246 17 a| Regenerative medicine GAO-23-105430;

264 1 a| Washington, DC :b| United States Government Accountability Office,c| 2023.;

300 a| 1 online resource (iii, 46 pages) :b| color illustrations.;

336 a| textb| txt2| rdacontent;

337 a| computerb| c2| rdamedia;

338 a| online resourceb| cr2| rdacarrier;

490 1 a| Technology assessment / United States Government Accountability Office;

500 a| "July 2023.";

500 a| "GAO-23-105430.";

500 a| In scope of the U.S. Government Publishing Office Catalog and Indexing Program (C&I) and Federal Depository Library Program (FDLP).;

500 a| GPO Cataloging Record Distribution Program (CRDP).;

504 a| Includes bibliographical references.;

588 a| Description based on online resource; title from PDF title page (GAO, viewed October 26, 2023).;

650 0 a| Regenerative medicinez| United States.=| ^A1042724;

650 0 a| Regenerative medicinex| Methodology.=| ^A1042724;

650 0 a| Regenerative medicinex| Technological innovations.=| ^A1042724;

650 0 a| Tissue engineeringz| United States.=| ^A652471;

650 0 a| Medical policyz| United States.=| ^A775;

810 1 a| United States.b| Government Accountability Office.t| Technology assessment.=| ^A1459509;

856 40 u| https://purl.fdlp.gov/GPO/gpo2195187| 0;

922 a| BIBCONEW 20231026;

949 a| Click on web addressw| asish| joyner94;

596 a| 1;

998 a| 6276930;

999 a| CLICK ON WEB ADDRESSw| ASISc| 1i| 6276930-1001l| JNETm| JOYNERr| Ys| Yt| JNE1DOu| 11/15/2023x| EDOCUMENTz| JERESOURCE;

Regenerative medicine : therapeutic applications, challenges, and policy options : report to congressional committees / United States Government Accountability Office.

Author/creator	United States
Format	Electronic
Publication	Washington, DC : United States Government Accountability Office, 2023.
Description	1 online resource (iii, 46 pages) : color illustrations.
Supplemental Content	https://purl.fdlp.gov/GPO/gpo219518
Subjects	Regenerative medicine--United States. Regenerative medicine--Methodology. Regenerative medicine--Technological innovations. Tissue engineering--United States. Medical policy--United States.

Running title	Regenerative medicine GAO-23-105430
Series	Technology assessment / United States Government Accountability Office United States. Government Accountability Office. Technology assessment. ^A1459509
General note	"July 2023."
General note	"GAO-23-105430."
General note	In scope of the U.S. Government Publishing Office Catalog and Indexing Program (C&I) and Federal Depository Library Program (FDLP).
General note	GPO Cataloging Record Distribution Program (CRDP).
Bibliography note	Includes bibliographical references.
Source of description	Description based on online resource; title from PDF title page (GAO, viewed October 26, 2023).
Technical rpt number	GAO-23-105430
GPO item number	0546-D (online)
Govt. docs number	GA 1.13:GAO-23-105430

Availability

Library	Location	Call Number	Status	Item Actions
	Electronic Resources	Access Content Online	✔ Available

Regenerative medicine : therapeutic applications, challenges, and policy options : report to congressional committees / United States Government Accountability Office.

Click here for more information about this title

Availability